Psoriasis and pemphigus vulgaris are immune-mediated cutaneous conditions that, when severe, can significantly diminish the quality of life of affected patients. Treatments for both conditions may consist of immunosuppression such as glucocorticoids or calcineurin inhibitors, biological agents, immunomodulatory approaches, and therapies targeting the underlying cellular abnormality. This chapter will focus on the biology and treatment of psoriasis and pemphigus vulgaris as well as the role of either high-dose chemotherapy with autologous stem cell support or allogeneic hematopoietic transplantation.